Washington, April 1: Scientists at Wake Forest University School of Medicine have reached a step closer to developing a new drug to inhibit tumour growth in cancer patients, and potentially help in the healing of wounds.
The researchers looked at angiogenesis - the body''s formation of new blood vessels from existing blood vessels - and how some blood proteins are involved in that process and affect blood vessel growth during a study.
They found that a protein called ferritin binds to and cripples the ability of another blood protein, called HKa, to shut down blood vessel growth.
The researcher point out that new blood vessels supply a steady stream of nutrients and oxygen, which are essential for tumour growth.